Skip to content
LATEST
Health

Drug-Resistant Pathogens Cause 50,800 Annual Deaths and $12 Billion in Healthcare Costs

Drug-resistant pathogens cause 50,800 U.S. deaths annually, with hospital infections costing $12 billion due to rising antibiotic resistance.

Drug-Resistant Pathogens Cause 50,800 Annual Deaths and $12 Billion in Healthcare Costs

Drug-resistant bacteria and fungi are responsible for approximately 9.7 million infections and 50,800 deaths annually in the United States. Hospital-acquired infections account for over 42,000 of these fatalities, imposing a financial burden exceeding $12 billion on healthcare system. These figures represent a significant increase from previous reporting periods, though officials note that methodological changes limit direct historical comparisons.

The report identifies 19 specific pathogens, categorizing four as urgent threats: Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales (CRE), and drug-resistant Neisseria gonorrhoeae. Candida auris, in particular, has seen a tenfold increase in cases over the last decade, with a 50% rise recorded between 2022 and 2023.

Medical experts attribute the rise in resistant strains to the systemic overuse of antibiotics, particularly for viral infections where such treatments are ineffective. This practice creates selective pressure, allowing resistant bacterial and fungal populations to proliferate. Public health strategies now prioritize enhanced antibiotic stewardship and improved hygiene protocols to mitigate the spread of these pathogens within healthcare and community settings.

More stories

Latest news